Morgan Stanley’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30.5M | Sell |
1,453,377
-233,211
| -14% | -$4.9M | ﹤0.01% | 2398 |
|
2025
Q1 | $27.6M | Buy |
1,686,588
+131,508
| +8% | +$2.15M | ﹤0.01% | 2359 |
|
2024
Q4 | $40M | Buy |
1,555,080
+1,194,443
| +331% | +$30.7M | ﹤0.01% | 2046 |
|
2024
Q3 | $11.4M | Sell |
360,637
-423,488
| -54% | -$13.4M | ﹤0.01% | 3327 |
|
2024
Q2 | $27.5M | Buy |
784,125
+20,507
| +3% | +$720K | ﹤0.01% | 2325 |
|
2024
Q1 | $33.5M | Sell |
763,618
-1,702,924
| -69% | -$74.7M | ﹤0.01% | 2139 |
|
2023
Q4 | $87.8M | Buy |
2,466,542
+2,233,766
| +960% | +$79.5M | ﹤0.01% | 1859 |
|
2023
Q3 | $6.28M | Sell |
232,776
-119,790
| -34% | -$3.23M | ﹤0.01% | 3551 |
|
2023
Q2 | $8.29M | Buy |
352,566
+261,814
| +288% | +$6.15M | ﹤0.01% | 3342 |
|
2023
Q1 | $1.25M | Buy |
90,752
+32,635
| +56% | +$448K | ﹤0.01% | 4734 |
|
2022
Q4 | $1.06M | Buy |
58,117
+9,085
| +19% | +$165K | ﹤0.01% | 4840 |
|
2022
Q3 | $732K | Sell |
49,032
-37,023
| -43% | -$553K | ﹤0.01% | 5067 |
|
2022
Q2 | $1.19M | Sell |
86,055
-34,784
| -29% | -$479K | ﹤0.01% | 4911 |
|
2022
Q1 | $1.35M | Buy |
120,839
+81,646
| +208% | +$913K | ﹤0.01% | 4785 |
|
2021
Q4 | $926K | Buy |
39,193
+11,810
| +43% | +$279K | ﹤0.01% | 5130 |
|
2021
Q3 | $698K | Buy |
27,383
+15,825
| +137% | +$403K | ﹤0.01% | 5302 |
|
2021
Q2 | $243K | Buy |
11,558
+11,327
| +4,903% | +$238K | ﹤0.01% | 5914 |
|
2021
Q1 | $6K | Sell |
231
-11,719
| -98% | -$304K | ﹤0.01% | 7059 |
|
2020
Q4 | $167K | Buy |
11,950
+7,341
| +159% | +$103K | ﹤0.01% | 5678 |
|
2020
Q3 | $58K | Sell |
4,609
-2,107
| -31% | -$26.5K | ﹤0.01% | 5673 |
|
2020
Q2 | $96K | Buy |
6,716
+6,192
| +1,182% | +$88.5K | ﹤0.01% | 5418 |
|
2020
Q1 | $2K | Sell |
524
-376
| -42% | -$1.44K | ﹤0.01% | 6385 |
|
2019
Q4 | $7K | Buy |
+900
| New | +$7K | ﹤0.01% | 6344 |
|